Effective July 1, 2026, Nestlé Health Science and Nestlé Nutrition have merged. As we make the transition, you will see some changes to this website.

Choose language:

Open Menu

Ford K., Gilbertson H., Clinical Use of Peptide-Based Formula (Peptamen Junior®, Nestlé) in the Paediatric Population. Int J of Nut. 2022. Vol 6,4: 35-45.

Clinical Use of Peptide-Based Formula (Peptamen Junior®, Nestlé) in the Paediatric Population.

This retrospective study showed that 318 patients, with a variety of pathologies and complex medical conditions tolerated the peptide-based formula, both by tube and orally.

This site is intended only for Canadian healthcare professionals. The products discussed in this site may have different product labeling in different countries.
In the event of a discrepancy between website information and product packaging, please refer to product packaging.
The information provided is for educational purposes only.

All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland and used under license. ©2026 Nestlé.